North Carolina achieved a record-breaking year for life sciences investments in 2024. Twenty-five companies announced ...
Metsera is aiming to put its weight loss drug MET-097i, which boasts of a longer half-life, through Phase III trials.
Daily Star on MSN49m
Singer claims she has osteoporosis following 'Ozempic use' after she was called 'too fat'A singer has said that she was diagnosed with osteoporosis after she used Ozempic, a drug not licensed for weight loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback